Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94.
Valproate is a standard treatment for bipolar disorder and a first-line mood stabilizer. The molecular mechanisms underlying its actions in bipolar disorder are unclear. It has been suggested that the action of valproate is linked to changes in gene expression and induction of endoplasmic reticulum...
Main Authors: | Chihiro Kakiuchi, Shinsuke Ishigaki, Christine M Oslowski, Sonya G Fonseca, Tadafumi Kato, Fumihiko Urano |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2607540?pdf=render |
Similar Items
-
Loss of Function of WFS1 Causes ER Stress-Mediated Inflammation in Pancreatic Beta-Cells
by: Shuntaro Morikawa, et al.
Published: (2022-03-01) -
Targeted Deletion of ER Chaperone GRP94 in the Liver Results in Injury, Repopulation of GRP94-Positive Hepatocytes, and Spontaneous Hepatocellular Carcinoma Development in Aged Mice
by: Wan-Ting Chen, et al.
Published: (2014-08-01) -
Structural insights into complexes of glucose-regulated Protein94 (Grp94) with human immunoglobulin G. relevance for Grp94-IgG complexes that form in vivo in pathological conditions.
by: Andrea Pagetta, et al.
Published: (2014-01-01) -
Co-downregulation of GRP78 and GRP94 induces apoptosis and inhibits migration in prostate cancer cells
by: Lu Tong, et al.
Published: (2019-07-01) -
Valproate for acute mood episodes in bipolar disorder.
by: Macritchie, K, et al.
Published: (2003)